Evidence map›Paper›PMID 15340079›Full record

ArticleMolecular and cellular biology2004

Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro.

Eugenia Trushina, Roy B Dyer, John D Badger, Daren Ure, Lars Eide, David D Tran, Brent T Vrieze, Valerie Legendre-Guillemin, Peter S McPherson, Bhaskar S Mandavilli and 12 more

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 251 papers.

0numbers the graph read from it
0cells of the map it votes in
251citing papers in PubMed
7.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

251 citing papers in PubMed, 505 citations in OpenAlex.

  1. Review
  2. International journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Quality control of protein import into mammalian mitochondria.Protein science : a publication of the Protein Society · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. SKOOTS: Skeleton-oriented object segmentation for mitochondria.bioRxiv : the preprint server for biology · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Mitochondrial Dysfunction in Repeat Expansion Diseases.Antioxidants (Basel, Switzerland) · 2023
    Review
  20. Review

191 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 4 countries.

Eugenia TrushinaDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo ClinicFoundation, Rochester, Minnesota 55905, USA.
Roy B Dyer
John D Badger
Daren Ure
Lars Eide
David D Tran
Brent T Vrieze
Valerie Legendre-Guillemin
Peter S McPherson
Bhaskar S Mandavilli
Bennett Van Houten
Scott Zeitlin
Mark McNiven
Ruedi Aebersold
Michael Hayden
Joseph E Parisi
Erling Seeberg
Ioannis Dragatsis
Kelly Doyle
Anna Bender
Celin Chacko
Cynthia T McMurray
Mayo Clinic in Arizona · USMontreal Neurological Institute and Hospital · CANational Institute of Environmental Health Sciences · USInstitute for Systems Biology · USInstitute of Neuroimmunology of the Slovak Academy of Sciences · SKMayo Clinic · USOslo University Hospital · NOUniversity of British Columbia · CAUniversity of Oslo · NOUniversity of Tennessee Health Science Center · USUniversity of Virginia · US

Funding

BRAIN TISSUE RESOURCE OFR NEUROPSYCHIATRIC RESEARCHR01MH031862 · NIMH · MC LEAN HOSPITAL (BELMONT, MA) · PI BENES, FRANCINE M. · 1985 to 2002
$3.6M
TRAFFICKING DEFECTS IN HUNTINGTONS DISEASER01NS040738 · NINDS · MAYO CLINIC ROCHESTER · PI MCMURRAY, CYNTHIA THERESE · 2001 to 2009
$3.4M
Consequences Of Mitochondrial DNA DamageZ01ES061062 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI VAN HOUTEN, BENNETT · 1999 to 2008
$1.2M
NIDDK NIH HHS DK 43694-01NIMH NIH HHS MH/NS 31862NINDS NIH HHS NS40738NINDS NIH HHS R01 NS040738
6 · The paper itself

Abstract

Recent data in invertebrates demonstrated that huntingtin (htt) is essential for fast axonal trafficking. Here, we provide direct and functional evidence that htt is involved in fast axonal trafficking in mammals. Moreover, expression of full-length mutant htt (mhtt) impairs vesicular and mitochondrial trafficking in mammalian neurons in vitro and in whole animals in vivo. Particularly, mitochondria become progressively immobilized and stop more frequently in neurons from transgenic animals. These defects occurred early in development prior to the onset of measurable neurological or mitochondrial abnormalities. Consistent with a progressive loss of function, wild-type htt, trafficking motors, and mitochondrial components were selectively sequestered by mhtt in human Huntington's disease-affected brain. Data provide a model for how loss of htt function causes toxicity; mhtt-mediated aggregation sequesters htt and components of trafficking machinery leading to loss of mitochondrial motility and eventual mitochondrial dysfunction.

Indexed as

MutationAgingAnimalsAxonal TransportBase SequenceBrainDNAHumansHuntingtin ProteinHuntington DiseaseIn Vitro TechniquesMiceMice, KnockoutMice, TransgenicMicroscopy, ElectronMitochondriaDNAHTT protein, humanHtt protein, mouseHuntingtin ProteinNerve Tissue ProteinsNuclear ProteinsRecombinant Proteins

Identifiers

PMID15340079
PMCPMC515048
OpenAlexW2150852495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.